Magellan Robotic System. Image courtesy of Hansen Medical.
October 29, 2015 — Hansen Medical Inc. announced the shipment of the Magellan Robotic System to Holy Name Medical Center in Teaneck, New Jersey, the first hospital in the New York/New Jersey metropolitan area to purchase a system.
"We are excited for Holy Name Medical Center to be the first institution in the New York/New Jersey metropolitan area to offer robotic endovascular procedures with the Magellan Robotic System," said John Rundback, M.D., interventional radiologist and director of the Interventional Institute at Holy Name Medical Center. "The acquisition of a Magellan system by Holy Name reinforces our commitment to providing the most advanced, minimally invasive treatment options to patients in the region. We look forward to offering precise and predictable robotic procedures for the treatment of a wide variety of conditions, including peripheral vascular disease, uterine fibroids, cancer and enlarged prostates."
The Magellan Robotic System is an advanced technology that drives Magellan Robotic Catheters and guide wires during minimally invasive endovascular procedures. Magellan is designed to offer procedural predictability, precision and catheter stability as physicians navigate inside blood vessels and deliver therapy.
Image-guided medical procedures using interventional fluoroscopy, while growing rapidly, are the leading source of occupational ionizing radiation exposure for medical personnel. Magellan's remote workstation allows physicians to control robotic catheters and guide wires while seated away from the radiation field, which has been shown to reduce radiation exposure for the physician by as much as 95 percent in complex endovascular procedures.
For more information: www.hansenmedical.com
January 27, 2026 
